PCR23 Methodological Considerations Related to Patient-Reported Outcomes Data (PRO) within HTA Appraisals Reviewed By Institut Für Qualität Und Wirtschaftlichkeit Im Gesundheitswesen (IQWIG) – Example of Triple-Negative Breast Cancer
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1803
https://www.valueinhealthjournal.com/article/S1098-3015(23)01903-4/fulltext
Title :
PCR23 Methodological Considerations Related to Patient-Reported Outcomes Data (PRO) within HTA Appraisals Reviewed By Institut Für Qualität Und Wirtschaftlichkeit Im Gesundheitswesen (IQWIG) – Example of Triple-Negative Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01903-4&doi=10.1016/j.jval.2023.03.1803
First page :
Section Title :
Open access? :
No
Section Order :
11128